Results for tag: "Thromboelastography"

Thromboelastography (TEG) is a diagnostic test used to assess the clotting ability of a patient's blood. It is used in the cardiovascular device market to measure the speed and strength of clot formation, as well as the rate of clot breakdown. TEG is used to diagnose and monitor a variety of conditions, including deep vein thrombosis, disseminated intravascular coagulation, and heparin-induced thrombocytopenia. It is also used to monitor the effectiveness of anticoagulant therapy and to assess the risk of bleeding in patients undergoing surgery. TEG is a valuable tool for clinicians in the cardiovascular device market, as it provides a comprehensive assessment of a patient's clotting ability. It is also used to monitor the effectiveness of anticoagulant therapy and to assess the risk of bleeding in patients undergoing surgery. Some companies in the Thromboelastography market include Haemonetics Corporation, Sienco Inc., Helena Laboratories, and Diagnostica Stago. Show Less Read more